Related references
Note: Only part of the references are listed.4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
Introduction: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
7. Diabetes Technology: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Rajiv Agarwal et al.
EUROPEAN HEART JOURNAL (2022)
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
Rajiv Agarwal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis
Victor Razuk et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
Cynthia Delgado et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE
Ian H. de Boer et al.
KIDNEY INTERNATIONAL (2022)
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project
Katherine R. Tuttle et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Michael G. Shlipak et al.
KIDNEY INTERNATIONAL (2021)
The Patient Voice in Health Care Decision Making The Perspective of People Living with Diabetes and CKD
Tami Sadusky et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
SGLT2 Inhibitors in Diabetic Kidney Disease
Sophia Zoungas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Rationale and design of the Kidney Precision Medicine Project
Ian H. de Boer et al.
KIDNEY INTERNATIONAL (2021)
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Abstracts
[Anonymous]
KIDNEY INTERNATIONAL (2021)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
Lauren A. Eberly et al.
JAMA NETWORK OPEN (2021)
Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 US Health Care Organizations
Nikita Stempniewicz et al.
DIABETES CARE (2021)
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers A Multinational Cohort Study
RuiJun Chen et al.
HYPERTENSION (2021)
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
Glenn M. Chertow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Race, Genetic Ancestry, and Estimating Kidney Function in CKD
C. Hsu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
Natalie Staplin et al.
ECLINICALMEDICINE (2021)
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
M. Angelyn Bethel et al.
DIABETES CARE (2020)
Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Rhys Williams et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study
Raymond R. Townsend et al.
KIDNEY INTERNATIONAL (2020)
CKD Awareness Among US Adults by Future Risk of Kidney Failure
Chi D. Chu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up
Hsuan-Ying Chen et al.
DIABETES CARE (2020)
The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study
Eric Yuk Fai Wan et al.
DIABETES CARE (2020)
FOREWORD
Alison Steiber et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2 Subgroup Analysis of the Randomized CREDENCE Trial
George Bakris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN) Phase 3 Randomized Controlled Clinical Trial
Sadayoshi Ito et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
Thea Anine Strom Halden et al.
DIABETES CARE (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Chronic Kidney Disease Diagnosis and Management: A Review
Teresa K. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
Moritz Mahling et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
Appraisal of Non-Cardiovascular Safety for Sodium-Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials
Fang-Hong Shi et al.
FRONTIERS IN PHARMACOLOGY (2019)
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
Brendan L. Neuen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
Elisabeth Schwaiger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Use of Empagliflozin in Recipients of Kidney Transplant: A Report of 8 Cases
Nizar Attallah et al.
TRANSPLANTATION PROCEEDINGS (2019)
Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
Matthew G. Cehic et al.
TRANSPLANTATION DIRECT (2019)
Individualizing Blood Pressure Targets for People With Diabetes and Hypertension Comparing the ADA and the ACC/AHA Recommendations
Ian H. de Boer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Katherine R. Tuttle et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Results From the LEADER Trial
Johannes F. E. Mann et al.
CIRCULATION (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez et al.
LANCET (2018)
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Adeera Levin et al.
LANCET (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
American Diabetes Association Standards of Medical Care in Diabetes 2017
Payal H. Marathe et al.
JOURNAL OF DIABETES (2017)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Ian H. de Boer et al.
DIABETES CARE (2017)
Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in US Integrated Health Care Delivery Systems: 2005-2011
Ram D. Pathak et al.
DIABETES CARE (2016)
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
Maryam Afkarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review
Silvio E. Inzucchi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The accuracy of predicting cardiovascular death based on one compared to several albuminuria values
Gudrun Hatlen et al.
KIDNEY INTERNATIONAL (2014)
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
Christoph Wanner et al.
KIDNEY INTERNATIONAL (2014)
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
Paul E. Stevens et al.
ANNALS OF INTERNAL MEDICINE (2013)
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
Caroline S. Fox et al.
LANCET (2012)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
C. Baigent et al.
AMERICAN HEART JOURNAL (2010)
Optimizing Insulin Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus: Optimal Dosing and Timing in the Outpatient Setting
Allison J. Hahr et al.
DM DISEASE-A-MONTH (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): Demographic and baseline characteristics
C Wanner et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2004)
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study
WF Keane et al.
KIDNEY INTERNATIONAL (2003)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)